Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.

We undertook this study to examine the accuracy of plasma C-peptide as a marker of insulin secretion. The peripheral kinetics of biosynthetic human C-peptide (BHCP) were studied in 10 normal volunteers and 7 insulin-dependent diabetic patients. Each subject received intravenous bolus injections of BHCP as well as constant and variable rate infusions. After intravenous bolus injections the metabolic clearance rate of BHCP (3.8 +/- 0.1 ml/kg per min, mean +/- SEM) was not significantly different from the value obtained during its constant intravenous infusion (3.9 +/- 0.1 ml/kg per min). The metabolic clearance rate of C-peptide measured during steady state intravenous infusions was constant over a wide concentration range. During experiments in which BHCP was infused at a variable rate, the peripheral concentration of C-peptide did not change in proportion to the infusion rate. Thus, the infusion rate of BHCP could not be calculated accurately as the product of the C-peptide concentration and metabolic clearance rate. However, the non-steady infusion rate of BHCP could be accurately calculated from peripheral C-peptide concentrations using a two-compartment mathematical model when model parameters were derived from the C-peptide decay curve in each subject. Application of this model to predict constant infusions of C-peptide from peripheral C-peptide concentrations resulted in model generated estimates of the C-peptide infusion rate that were 101.5 +/- 3.4% and 100.4 +/- 2.8% of low and high dose rates, respectively. Estimates of the total quantity of C-peptide infused at a variable rate over 240 min based on the two-compartment model represented 104.6 +/- 2.4% of the amount actually infused. Application of this approach to clinical studies will allow the secretion rate of insulin to be estimated with considerable accuracy. The insulin secretion rate in normal subjects after an overnight fast was 89.1 pmol/min, which corresponds with a basal 24-h secretion of 18.6 U.

[1]  K. Polonsky,et al.  C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. , 1984, The Journal of clinical investigation.

[2]  K. Polonsky,et al.  C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations , 1984, Diabetes.

[3]  W. Waldhäusl,et al.  Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans. , 1984, Metabolism: clinical and experimental.

[4]  K. Polonsky,et al.  Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. , 1983, The Journal of clinical investigation.

[5]  S. Margolis,et al.  Hyperinsulinemia of obesity is due to decreased clearance of insulin. , 1983, The American journal of physiology.

[6]  R. Eaton,et al.  Hepatic removal of insulin in normal man: dose response to endogenous insulin secretion. , 1983, The Journal of clinical endocrinology and metabolism.

[7]  E. Bonora,et al.  Decreased hepatic insulin extraction in subjects with mild glucose intolerance. , 1983, Metabolism: clinical and experimental.

[8]  H. Kehlet,et al.  Discrepancy Between Plasma C-Peptide and Insulin Response to Oral and Intravenous Glucose , 1983, Diabetes.

[9]  K. Polonsky,et al.  Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism. , 1983, Acta endocrinologica.

[10]  R. Casamitjana,et al.  Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels. , 1983, The Journal of clinical endocrinology and metabolism.

[11]  W. Waldhäusl,et al.  Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects. , 1982, The American journal of physiology.

[12]  J. Hoekstra,et al.  C-Peptide , 1982, Diabetes Care.

[13]  M. Rendell,et al.  Estimation of the Secretion Rate of Insulin from the Urinary Excretion Rate of C-Peptide: Study in Obese and Diabetic Subjects , 1982, Diabetes.

[14]  C. Boddie-Willis,et al.  Urinary C-peptide: an indicator of beta-cell secretion under different metabolic conditions. , 1982, The Journal of clinical endocrinology and metabolism.

[15]  K. Polonsky,et al.  Glucose ingestion in dogs alters the hepatic extraction of insulin. In vivo evidence for a relationship between biologic action and extraction of insulin. , 1982, The Journal of clinical investigation.

[16]  H. Kehlet,et al.  Decreased insulin removal contributes to hyperinsulinemia in obesity. , 1981, The Journal of clinical endocrinology and metabolism.

[17]  Z. Zadik,et al.  Correlation of Urinary Excretion of C-Peptide with the Integrated Concentration and Secretion Rate of Insulin , 1981, Diabetes.

[18]  K. Kosaka,et al.  Isoproterenol-stimulated C-peptide and insulin secretion in diabetic and nonobese normal subjects: decreased hepatic extraction of endogenous insulin in diabetes. , 1980, The Journal of clinical endocrinology and metabolism.

[19]  K. M. Erickson,et al.  Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. , 1980, The Journal of clinical endocrinology and metabolism.

[20]  P. Savage,et al.  C-Peptide and insulin secretion in Pima Indians and Caucasians: constant fractional hepatic extraction over a wide range of insulin concentrations and in obesity. , 1979, The Journal of clinical endocrinology and metabolism.

[21]  D L Horwitz,et al.  Kinetics of human connecting peptide in normal and diabetic subjects. , 1978, The Journal of clinical investigation.

[22]  H. Kuzuya,et al.  Characterization of Seven C-peptide Antisera , 1978, Diabetes.

[23]  J. A. Scarlett,et al.  Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies. , 1977, The New England journal of medicine.

[24]  J. Field,et al.  Effect of infusion of insulin into portal vein on hepatic extraction of insulin in anesthetized dogs. , 1975, The American journal of physiology.

[25]  M Berman,et al.  A model of the kinetics of insulin in man. , 1974, The Journal of clinical investigation.

[26]  J. Field,et al.  Effect of intraduodenal glucose administration on hepatic extraction of insulin in the anesthetized dog. , 1973, The Journal of clinical investigation.

[27]  D. Steiner,et al.  The metabolism of proinsulin and insulin by the liver. , 1972, The Journal of clinical investigation.

[28]  C. Metzler.  Usefulness of the Two-Compartment Open Model in Pharmacokinetics , 1971 .

[29]  D. Steiner,et al.  Secretion of Proinsulin C-Peptide by Pancreatic β Cells and its Circulation in Blood , 1969, Nature.

[30]  L. Madison.  Role of insulin in the hepatic handling of glucose. , 1969, Archives of internal medicine.

[31]  A. Lazarow,et al.  Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats , 1963, Diabetes.